AT MOON VENTURES, a fintech company, has announced strategic collaborations with various banks, including Suryoday Small ...

The FDA has granted marketing authorization to CT-132 for the preventive treatment of episodic migraine in patients aged 18 years and older.

A growing and more diverse pipeline means that there is a greater need for digital innovations, which can address ...

D-150 is a potential backbone therapy that is designed to provide multi-year sustained delivery of anti-VEGF (aflibercept and ...

Sidekick Health has secured a €35 million venture debt facility from the European Investment Bank (EIB) to advance its digital health and thera ...

In this week’s edition of InnovationRx, we look at a patent fight over the world’s top-selling drug, breakthroughs from the ...

Ancestry will work with HBCUs to preserve their historical documents and rarely seen photography A Media Snippet accompanying ...

SHANGHAI, April 21, 2025 /PRNewswire/ -- Rona Therapeutics, a biotechnology company pioneering innovative RNA-targeted therapies, announced that the Investigational New Drug (IND) application for ...

Treatments emerging from the digital therapeutics space were once greeted with optimism, due to the potential to aid patients’ health through technology, rather than pharmaceuticals. Ben ...

The U.S. digital therapeutics market size was valued at $1.16 billion in 2019 and is expected to reach $5.08 billion by 2027 with a CAGR of 19.2% during the forecast period. Increase in adoption of ...

Commercial stage pharmaceutical firm Shield Therapeutics, which has a base in Gateshead, is entering the second quarter of its financial year with "clear momentum", despite the first quarter being ...